Skip to main content

Table 3 Efficacy of IV lignocaine in fibromyalgia

From: Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome

Dimension

Variable

Pre-Treatment Averagea

Post-Treatment Averagea

Test Statisticb

P

Sensory

Pain

9

5

5.74

< 0.001

 

Pain Relief

9

5

5.11

< 0.001

 

Hours/Day in Pain

22.97

17.42

4.27

< 0.001

Psychological

Depression

8

5

4.32

< 0.001

 

Quality of life

9

6

4.94

< 0.001

 

Coping

9

5

5.45

< 0.001

 

Dependency

8

5

3.70

< 0.001

Sociological

Sleep

9

5

5.20

< 0.001

 

Work

10

10

2.63

NS

 

Social Life

10

7

4.81

< 0.001

 

Sex Life

9

7.5

3.36

< 0.001

 

Driving

6.5

4.5

3.77

< 0.001

 

Housework

8

7

4.18

< 0.001

 

Mobility

9

7

4.22

< 0.001

  1. a The reported average is the median for all variables, except in the case of Hours/Day in Pain, where the mean is given. b The reported statistic is the Z score converted from the Wilcoxon signed ranks test for all variables, except in the case of Hours/Day in Pain, where the t statistic is given.